RecruitingNCT03718364

Swiss Atrial Fibrillation Pulmonary Vein Isolation Registry


Sponsor

University Hospital, Basel, Switzerland

Enrollment

3,000 participants

Start Date

Jul 1, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

Registry of patients with atrial fibrillation undergoing catheter-based ablation of atrial fibrillation (pulmonary vein isolation) to determine long-term success rates of catheter-based ablation of atrial fibrillation (pulmonary vein isolation) and to evaluate factors associated with long-term success of catheter-based ablation of atrial fibrillation (pulmonary vein isolation).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This registry is collecting data from patients in Switzerland who are undergoing a catheter-based heart procedure called pulmonary vein isolation (PVI) to treat atrial fibrillation (an irregular heart rhythm), to better understand real-world outcomes and improve the procedure over time. **You may be eligible if...** - You are scheduled to have catheter ablation (pulmonary vein isolation) for atrial fibrillation (an irregular heartbeat condition) **You may NOT be eligible if...** - You are unwilling or unable to participate in this registry Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREcatheter-based ablation of atrial fibrillation (pulmonary vein isolation)

catheter-based ablation of atrial fibrillation (pulmonary vein isolation)


Locations(2)

Cardiology/Electrophysiology, University Hospital Basel

Basel, Switzerland

University Hospital Bern

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03718364